About Healthcare News
FTC sues main pharmacy profit managers in excess of insulin selling prices The company introduced motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of lifetime-saving insulin medicines.Elevance lowers guidance on ‘unprecedented’ Me